Anagrelide hydrochloride: Risk of thrombosis including cerebral infarction upon abrupt treatment discontinuation

Anagrelide hydrochloride: Risk of thrombosis including cerebral infarction upon abrupt treatment discontinuation

File Type: pdf
Categories: Communication To Health Care Professionals
Tags: Pharmacovigilance